JP2023134519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023134519A5 JP2023134519A5 JP2023104857A JP2023104857A JP2023134519A5 JP 2023134519 A5 JP2023134519 A5 JP 2023134519A5 JP 2023104857 A JP2023104857 A JP 2023104857A JP 2023104857 A JP2023104857 A JP 2023104857A JP 2023134519 A5 JP2023134519 A5 JP 2023134519A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- novel products
- manufacture substantially
- manufacture
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Claims (1)
- 本願明細書に実質的に記載された、新規な物、方法及び製造方法。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762527466P | 2017-06-30 | 2017-06-30 | |
| US62/527,466 | 2017-06-30 | ||
| JP2019572486A JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
| PCT/EP2018/067494 WO2019002512A2 (en) | 2017-06-30 | 2018-06-28 | GLYCOPROTEINS CUSTOMIZED FROM ENGINEERING AND FULLY FUNCTIONAL |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Division JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023134519A JP2023134519A (ja) | 2023-09-27 |
| JP2023134519A5 true JP2023134519A5 (ja) | 2024-02-08 |
Family
ID=62815031
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Active JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
| JP2023104857A Pending JP2023134519A (ja) | 2017-06-30 | 2023-06-27 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572486A Active JP7437162B2 (ja) | 2017-06-30 | 2018-06-28 | 改変されかつ完全に機能カスタマイズされた糖タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11913051B2 (ja) |
| EP (1) | EP3645732A2 (ja) |
| JP (2) | JP7437162B2 (ja) |
| KR (1) | KR20200022486A (ja) |
| CN (2) | CN117487873A (ja) |
| AU (1) | AU2018294504A1 (ja) |
| WO (1) | WO2019002512A2 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117487873A (zh) | 2017-06-30 | 2024-02-02 | 利玛泰克生物制品公司 | 工程化且完全-功能定制的糖蛋白 |
| WO2019234021A1 (en) | 2018-06-04 | 2019-12-12 | Limmatech Biologics Ag | Glycoengineered monoclonal antibody |
| EP4087921A1 (en) | 2020-01-07 | 2022-11-16 | Limmatech Biologics AG | Glycoengineering using leishmania cells |
| JP2023509734A (ja) | 2020-01-07 | 2023-03-09 | リンマテック バイオロジクス エージー | 操作されたＬｅｉｓｈｍａｎｉａ細胞 |
| US20240067714A1 (en) | 2020-09-14 | 2024-02-29 | Limmatech Biologics Ag | Fab sialylation of antibodies |
| CA3210709A1 (en) | 2021-03-23 | 2022-09-29 | Glycoera Ag | Glycan-mediated protein degradation |
| JP2024513755A (ja) | 2021-03-23 | 2024-03-27 | グリコエラ アーゲー | マンノース３グリカン媒介タンパク質分解 |
| EP4330383A1 (en) * | 2021-04-29 | 2024-03-06 | Novartis AG | Hypersialylating cells |
| WO2024068753A1 (en) | 2022-09-28 | 2024-04-04 | Glycoera Ag | Glycan-mediated protein degradation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1242602B1 (en) * | 1999-11-05 | 2008-02-13 | Jena Bioscience GmbH | Protein expression systems in non-pathogenic kinetoplastidae |
| US7863020B2 (en) | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
| CN101960017B (zh) * | 2008-01-03 | 2017-06-09 | 康乃尔研究基金会有限公司 | 原核生物中的糖基化蛋白表达 |
| KR20140091017A (ko) * | 2011-10-28 | 2014-07-18 | 머크 샤프 앤드 돔 코포레이션 | Alg3 발현이 결핍된 피키아 파스토리스 균주에서 n-글리칸 점유율을 증가시키고 하이브리드 n-글리칸의 생산을 감소시키는 방법 |
| JP7100584B2 (ja) | 2015-11-30 | 2022-07-13 | リンマテック バイオロジクス エージー | グリコシル化されたタンパク質を産生する方法 |
| CN117487873A (zh) | 2017-06-30 | 2024-02-02 | 利玛泰克生物制品公司 | 工程化且完全-功能定制的糖蛋白 |
| EP4087921A1 (en) | 2020-01-07 | 2022-11-16 | Limmatech Biologics AG | Glycoengineering using leishmania cells |
| JP2023509734A (ja) | 2020-01-07 | 2023-03-09 | リンマテック バイオロジクス エージー | 操作されたＬｅｉｓｈｍａｎｉａ細胞 |
| US20240067714A1 (en) | 2020-09-14 | 2024-02-29 | Limmatech Biologics Ag | Fab sialylation of antibodies |
-
2018
- 2018-06-28 CN CN202310864838.4A patent/CN117487873A/zh active Pending
- 2018-06-28 EP EP18736858.4A patent/EP3645732A2/en active Pending
- 2018-06-28 AU AU2018294504A patent/AU2018294504A1/en active Pending
- 2018-06-28 US US16/625,579 patent/US11913051B2/en active Active
- 2018-06-28 KR KR1020207002825A patent/KR20200022486A/ko not_active Application Discontinuation
- 2018-06-28 WO PCT/EP2018/067494 patent/WO2019002512A2/en active Application Filing
- 2018-06-28 JP JP2019572486A patent/JP7437162B2/ja active Active
- 2018-06-28 CN CN201880056874.5A patent/CN111108211A/zh active Pending
-
2023
- 2023-06-27 JP JP2023104857A patent/JP2023134519A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023134519A5 (ja) | ||
| JP2018100276A5 (ja) | ||
| JP2018012698A5 (ja) | ||
| JP2024038101A5 (ja) | ||
| JP2020010717A5 (ja) | ||
| WO2018081502A8 (en) | Synthetic bacteriophages and bacteriophage compositions | |
| JP2019142968A5 (ja) | ||
| JP1725654S (ja) | トラベルオーガナイザー | |
| JP2015081257A5 (ja) | ||
| JP2018184433A5 (ja) | ||
| JP2022166039A5 (ja) | ||
| JP2020109413A5 (ja) | ||
| JP2018186833A5 (ja) | ||
| JP2020528637A5 (ja) | ||
| JP1725584S (ja) | トラベルオーガナイザー | |
| JP2021129286A5 (ja) | ||
| JP2021185485A5 (ja) | ||
| JPWO2019183186A5 (ja) | ||
| JPWO2020257720A5 (ja) | ||
| JPWO2021165578A5 (ja) | ||
| JP1735813S (ja) | エアマットレス | |
| JPWO2020249002A5 (ja) | ||
| JP2022009681A5 (ja) | ||
| EP4065299A4 (en) | CERAMIC RODS AND DISCS, METHODS OF MANUFACTURING THEREOF, AND ARTICLES COMPRISING THE SAME | |
| SG11202105995QA (en) | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof |